Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuzo Ohno

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Journal of Advanced Nursing|February 20, 2002
Efficacy of the Shinki bioclean room for preventing infection in neutropenic patientsKaori Shinjo, Akihiro Takeshita, Mitsuaki Yanagi, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|September 15, 2004
Mutation analysis of SHIP gene in acute leukemiaJian-Min Luo, Ze-Lin Liu, Hong-Ling Hao, et al.
Shock (Augusta, Ga.)|November 12, 2010
Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trialNaoki Aikawa, Shuji Shimazaki, Yasuhiro Yamamoto, et al.
Cancer Research|March 1, 2005
Molecular target-based treatment of human cancer: summary of the 10th international conference on differentiation therapyArthur Zelent, Kevin Petrie, Zhu Chen, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 9, 2011
[Phase I study of nelarabine in patients with relapsed or refractory T-ALL/T-LBL]Keizo Horibe, Tetsuya Takimoto, Toshiya Yokozawa, et al.
International Journal of Hematology|October 7, 2005
Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapiesKazuyuki Shigeno, Kensuke Naito, Naohi Sahara, et al.
Internal Medicine (Tokyo, Japan)|September 15, 2005
Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia: a comparison to all-trans retinoic acid treatmentKaori Shinjo, Akihiro Takeshita, Naohi Sahara, et al.
International Journal of Hematology|June 8, 2006
Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapyKensuke Naito, Miki Kobayashi, Naohi Sahara, et al.
International Journal of Oncology|July 6, 2007
Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapyHitoshi Zembutsu, Masamitsu Yanada, Asahi Hishida, et al.
Journal of Gastroenterology|May 29, 2004
A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patientsAkira Sawaki, Kenji Yamao, Tsuneya Nakamura, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Journal of Advanced Nursing|February 20, 2002
Efficacy of the Shinki bioclean room for preventing infection in neutropenic patientsKaori Shinjo, Akihiro Takeshita, Mitsuaki Yanagi, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|September 15, 2004
Mutation analysis of SHIP gene in acute leukemiaJian-Min Luo, Ze-Lin Liu, Hong-Ling Hao, et al.
Shock (Augusta, Ga.)|November 12, 2010
Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trialNaoki Aikawa, Shuji Shimazaki, Yasuhiro Yamamoto, et al.
Cancer Research|March 1, 2005
Molecular target-based treatment of human cancer: summary of the 10th international conference on differentiation therapyArthur Zelent, Kevin Petrie, Zhu Chen, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 9, 2011
[Phase I study of nelarabine in patients with relapsed or refractory T-ALL/T-LBL]Keizo Horibe, Tetsuya Takimoto, Toshiya Yokozawa, et al.
International Journal of Hematology|October 7, 2005
Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapiesKazuyuki Shigeno, Kensuke Naito, Naohi Sahara, et al.
Internal Medicine (Tokyo, Japan)|September 15, 2005
Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia: a comparison to all-trans retinoic acid treatmentKaori Shinjo, Akihiro Takeshita, Naohi Sahara, et al.
International Journal of Hematology|June 8, 2006
Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapyKensuke Naito, Miki Kobayashi, Naohi Sahara, et al.
International Journal of Oncology|July 6, 2007
Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapyHitoshi Zembutsu, Masamitsu Yanada, Asahi Hishida, et al.
Journal of Gastroenterology|May 29, 2004
A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patientsAkira Sawaki, Kenji Yamao, Tsuneya Nakamura, et al.
Pageof 8